Proteomics investigation revealed that andrographolide inhibited JAK2/STAT3 signaling by downregulating the phosphorylation status of STAT3, which in turn decreased the expression of tumor PD-L1 in NSCLC [70]. This evidence concerns the gene STAT3 and neoplasm.